Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Viremia”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Not applicableWithdrawnNCT03033017
What this trial is testing

Predictors of Time to Viremia With an Analytic Treatment Interruption

Who this might be right for
HIV
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Not applicableNot Yet RecruitingNCT07015164
What this trial is testing

Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique - Hôpitaux de Paris 80
Not applicableLooking for participantsNCT06823596
What this trial is testing

The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY

Who this might be right for
Hiv
University of Toronto 26
Not applicableEnrolling By InvitationNCT06604663
What this trial is testing

Data Science and Qualitative Research for Decision Support in the HIV Care Cascade

Who this might be right for
Human Immunodeficiency VirusTreatment AdherenceTreatment Compliance+4 more
Brown University 80,000
Not applicableStudy completedNCT03618862
What this trial is testing

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

Who this might be right for
Hiv
Hospices Civils de Lyon 38
Post-approval studies (Phase 4)Study completedNCT00631449
What this trial is testing

Raltegravir Intensification in HIV-infected Patients

Who this might be right for
HIV Infections
University of California, San Francisco 30
Testing effectiveness (Phase 2)Looking for participantsNCT04513626
What this trial is testing

HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 150
Testing effectiveness (Phase 2)Ended earlyNCT02556333
What this trial is testing

Emtricitabine/Tenofovir Alafenamide as Salvage ART

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 1
Not applicableStudy completedNCT03198325
What this trial is testing

Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia

Who this might be right for
HIV Seropositivity
IRCCS San Raffaele 18
Not applicableEnded earlyNCT05219916
What this trial is testing

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Who this might be right for
Human Immunodeficiency Virus I Infection
Hospices Civils de Lyon 17
Large-scale testing (Phase 3)Study completedNCT00160329
What this trial is testing

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Who this might be right for
HyperlipidemiaHIV Infections
Stanford University 60
Not applicableLooking for participantsNCT07021092
What this trial is testing

PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY

Who this might be right for
HIV ViremiaHIV -1 Infection
Centre for Infectious Disease Research in Zambia 3,000
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT01034917
What this trial is testing

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

Who this might be right for
HIV
Germans Trias i Pujol Hospital 43
Load More Results